The AXL/Gas6 pathway is a potent EMT inducer and a metastatic phenotype promoter [29], that has been proposed as a pharmacological target in breast cancer for its role in controlling the invasive phenotype of cancer cells [67]. The gene discussed is GAS6; the disease is breast cancer.